Lower allopregnanolone during pregnancy predicts postpartum depression: An exploratory study

Psychoneuroendocrinology

Volumn 79, Issue , 2017, Pages 116-121

  Osborne, Lauren M ^a   Gispen, Fiona ^a   Sanyal, Abanti ^a   Yenokyan, Gayane ^a   Meilman, Samantha ^a   Payne, Jennifer L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; Depression; Hormones; Postpartum; Pregnancy; Reproductive

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; PROGESTERONE; ELTANOLONE;

ADULT; ARTICLE; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PREDICTION; PROGESTERONE BLOOD LEVEL; PUERPERAL DEPRESSION; RISK REDUCTION; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; YOUNG ADULT; ADOLESCENT; BLOOD; MIDDLE AGED; POSTNATAL DEPRESSION; PREDICTIVE VALUE; PREGNANCY;

ADOLESCENT; ADULT; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PREGNANOLONE; PROGESTERONE; YOUNG ADULT;

EID: 85014466604     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2017.02.012     Document Type: Article

References (54)

1. Abou-Saleh, M.T., Ghubash, R., Karim, L., Krymski, M., Bhai, I., Hormonal aspect of postpartum depression. Psychoneuroendocrinology 28:5 (1999), 465–475.
2. Backstrom, T., Bixo, M., Johansson, M., Nyberg, S., Ossewaarde, L., Ragagnin, G., Savic, I., Stromberg, J., Timby, E., van Broekhoven, F., van Wingen, G., Allopregnanolone and mood disorders. Prog. Neurobiol. 113 (2014), 88–94.
3. Bali, A., Jaggo, A.S., Multifunctional aspects of allopregnanolone in stress and related disorders. Prog. Neuro-Psychophparmacol. Biol. Psychiatry 48 (2014), 64–78.
4. Biggio, G., Cristina Mostallino, M., Follesa, P., Concas, A., Sanna, E., GABA(A) receptor function and gene expression during pregnancy and postpartum. Int. Rev. Neurobiol. 85 (2009), 73–94.
5. Bloch, M., Schmidt, P.J., Danaceau, M., Murphy, J., Nieman, L., Rubinow, D.R., Effects of gonadal steroids in women with a history of postpartum depression. Am. J. Psychiatry 157 (2000), 924–930.
6. Bristot, G., Ascoli, B., Gubert, C., Panizzutti, B., Kapczinski, F., Rosea, A.R., Progesterone and its metabolites and therapeutic targets in psychiatric disorders. Expert Opin. Ther. Targets 18:6 (2014), 679–690.
7. Chatzicharalampous, C., Rizos, D., Pliatsika, P., Leonardou, A., Hasiakos, D., Zervas, I., Alexandrou, A., Creatsa, M., Konidaris, S., Lambrinoudaki, I., Reproductive hormones and postpartum mood disturbances in Greek women. Gynecol. Endocrinol. 27:8 (2011), 543–550.
8. Chrousos, G.P., Torpy, D.J., Gold, P.W., Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann. Intern. Med. 129:3 (1998), 229–240.
9. Crowley, S.K., O'Buckley, T.K., Schiller, C.E., Stuebe, A., Morrow, A.L., Girdler, S.S., Blunted neuroactive steroid and HPA axis responses to stress are associated with reduced sleep quality and negative affect in pregnancy: a pilot study. Psychopharmacology 233 (2016), 1299–1310.
10. Deligiannidis, K.M., Sikoglu, E.M., Shaffer, S.A., Frederick, B., Svenson, A.E., Kopoyan, A., Kosma, C.A., Rothschild, A.J., Moore, C.M., GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study. J. Psychiatr. Res. 47 (2013), 816–828.
11. Deligiannidis, K.M., Kroll-Desrosiers, A.R., Mo, S., Nguyen, H.P., Svenson, A., Jaitly, N., Hall, J.E., Barton, B.A., Rothschild, A.J., Shaffer, S.A., Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression. Psychoneuroendocrinology 70 (2016), 98–107.
12. Douma, S.L., Husband, C., O'Donnell, M.E., Barwin, B.N., Woodend, A.K., Estrogen-related mood disorders: reproductive life cycle factors. Adv. Nurs. Sci. 28:4 (2005), 364–375.
13. Epperson, C.N., Gueorguieva, R., Czarkowski, K.A., Stiklus, S., Sellers, E., Krystal, J.H., Rothman, D.L., Mason, G.F., Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study. Psychopharmacology (Berl.) 186:3 (2006), 425–433.
14. Eser, D., Romeo, E., Baghai, T.C., di Michele, F., Schule, C., Pasini, A., et al. Neuroactive steroids as modulators of depression and anxiety. Neuroscience 138:3 (2006), 1041–1048.
15. Feksi, A., Harris, B., Walker, R.F., Riad-Fahmy, D., Newcombe, R.G., ‘Maternity Blues’ and hormone levels in saliva. J. Affect. Disord. 6 (1984), 351–355.
16. Gilbert Evans, S.E., Ross, L.E., Sellers, E.M., Purdy, R.H., Romach, M.K., 3α-reducted neuroactive steroids and their precursors during pregnancy and the postpartum period. Gynecol. Endocrinol. 21:November (5) (2005), 268–279.
17. Girdler, S.S., Straneva, P.A., Light, K.C., Pedersen, C.A., Morrow, A.L., Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol. Psychiatry 49:9 (2001), 788–797.
18. Girdler, S.S., Lindgren, M., Porcu, P., Rubinow, D., Johnson, J.L., Morrow, A.L., A history of depression in women is associated with an altered GABAergic neuroactive steroid profile. Psychoneuroendocrinology 37 (2012), 543–553.
19. Glynn, L.M., Davis, E.P., Sandman, C.A., New insights into the role of perinatal HPA-axis dysregulation in postpartum depression. Neuropeptides 47:6 (2013), 363–370.
20. Harris, B., Lovett, L., Newcombe, R.G., Read, G.F., Walker, R., Riad-Fahmy, D., Maternity blues and major endocrine changes: Cardiff puerperal mood and hormone study II. BMJ, 308, 1994.
21. Harris, B., Lovett, L., Smith, J., Read, G., Walker, R., Newcombe, R., Cardiff puerperal mood and hormone study. III Postnatal depression at 5 to 6 weeks postpartum, and its hormonal correlates across the peripartum period. Br. J. Psychiatry 168 (1996), 739–744.
22. Heidrich, A., Schleyer, M., Spingler, H., Albert, P., Knoche, M., Fritze, J., Lanczik, M., Postpartum blues: relationship between not-protein bound steroid hormones in plasma and postpartum mood changes. J. Affect. Disord. 30 (1994), 93–98.
23. Hellgren, C., Akerud, H., Skalkidou, A., Backstrom, T., Sundstrom-Poromaa, I., Low serum allopregnanolone is associated with symptoms of depression in late pregnancy. Neuropsychobiology 69 (2014), 147–153.
24. Kimmel, M., Hess, E., Roy, P.S., Palmer, J.T., Meltzer-Brody, S., Meuchel, J.M., Bost-Baxter, E., Payne, J.L., Family history, not lack of medication use, is associated with the development of postpartum depression in a high-risk sample. Arch. Womens Ment. Health 18:1 (2015), 113–121.
25. Klatzkin, R.R., Morrow, A.L., Light, K.C., Pedersen, C.A., Girdler, S.S., Histories of depression, allopregnanolone responses to stress, and premenstrual symptoms in women. Biol. Psychol. 71:1 (2006), 2–11.
26. Klier, C.M., Muzik, M., Dervic, K., Mossaheb, N., Benesch, T., Ulm, B., Zeller, M., The role of estrogen and progesterone in depression after birth. J. Psychiatr. Res. 41 (2007), 273–279.
27. Kuevi, V., Causon, R., Dixson, A.F., Everard, D.M., Hall, J.M., Hole, D., Whitehead, S.A., Wilson, C.A., Wise, J.C., Plasma amine and hormone changes in ‘post-partum blues’. Clin. Endocrinol. (Oxford) 19 (1983), 39–46.
28. Le Melledo, J.-M., Baker, G.B., Role of progeseorn and other neuroactive steroids in anxiety disorders. Expert Rev. Neurotherapeutics 4:5 (2004), 851–860.
29. Lindgren, M., Porcu, P., Rubinow, D.R., Johnson, J.L., Morrow, A.L., Girdler, S.S., A history of depression in women is associated with an altered GABAergic neuroactive steroid profile. Psychoneuroendocrinology 37 (2012), 543–553.
30. Maguire, J., Mody, I., GABAAR plasticity during pregnancy: relevance to postpartum depression. Neuron 59 (2008), 207–213.
31. McGregor, J.A., Hastings, C., Roberts, T., Barrett, J., Diurnal variation in saliva estriol level during pregnancy: a pilot study. Am. J. Obstet. Gynecol. 180:1 Pt. 3 (1999), S223–5.
32. Moses-Kolko, E.L., Berga, S.L., Kalro, B., Sit, D.K., Wisner, K.L., Transdermal estradiol for postpartum depression: a promising treatment option. Clin. Obstet. Gynecol. 52:3 (2009), 516–529.
33. Mostallino, M.C., Sanna, E., Concas, A., Biggio, G., Follesa, P., Plasticity and function of extrasynaptic GABA A receptors during pregnancy and after delivery. Psychoneuroendocrinology 34S (2009), S74–S83.
34. Nappi, R.E., Petraglia, F., Luisi, S., Polatti, F., Farina, C., Genazzani, A.R., Serum allopregnanolone in women with postpartum “blues”. Obstet. Gynecol. 97:1 (2001), 77–80.
35. Osborne, L.M., Kimmel, M., Clive, M., Guintivano, J., Brown, T., Cox, O., Judy, J., Brier, A., Beckmann, M.W., Kornhuber, J., Fasching, P.A., Goes, F., Payne, J.L., Gispen, F., Binder, E., Kaminsky, Z., Replication of Epigenetic postpartum depression biomarkers and variation with hormone levels. Neuropsychopharmacology 41:6 (2016), 1648–1658.
36. Padberg, F., di Michele, F., Zwanzger, P., Romeo, E., Bernardi, G., Schule, C., Baghai, T.C., Ella, R., Pasini, A., Rupprecht, R., Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression. Neuropsychopharmacology 27 (2002), 874–878.
37. Payne, J.L., Palmer, J.T., Joffe, H., A reproductive subtype of depression: conceptualizing models and moving toward etiology. Harv. Rev. Psychiatry 17:2 (2009), 72–86.
38. Pearson Murphy, B.E., Steinberg, S.I., Fen-Yun, H., Allison, C.M., Neuroactive ring α-reduced metabolites of progesterone in human plasma during pregnancy: elevated levels of 5α-dihydroprogesterone in depressed patients during the latter half of pregnancy. J. Clin. Endocrinol. Metab. 86:12 (2001), 5981–5987.
39. Pinna, G., Costa, E., Guidotti, A., Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at dosesthat are inactive on 55-HT reuptake. Psychopharmacology 186 (2006), 362–372.
40. Romeo, E., Strohle, A., Spalletta, G., di Michele, F., Hermann, B., Holsboer, F., Pasini, A., Rupprecht, R., Effects of antidepressant treatment on neuroactive steroids in major depression. Am. J. Psychiatry 155 (1998), 910–913.
41. Rubin, D.B., Multiple Imputation for Nonresponse in Surveys. 1987, Wiley, New York.
42. Schiller, C.E., Schmidt, P.J., Rubinow, D.R., Allopregnanolone as a mediator of affective switching in reproductive mood disorders. Psychopharmacology (Berl.) 231:17 (2014), 3557–3567.
43. Schiller, C.E., Meltzer-Brody, S., Rubinow, D.R., The role of reproductive hormones in postpartum depression. CNS Spectr. 20:1 (2015), 48–59.
44. Schule, C., Nothdurfter, C., Rupprecht, R., The role of allopregnanolone in depression and anxiety. Prog. Neurobiol. 113 (2014), 79–87.
45. Schumacher, M., Mattern, C., Ghoumari, A., Oudinet, J.P., Liere, P., Labombarda, F., Sitruk-Ware, R., De Nicola, A.F., Guennoun, R., Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors. Prog. Neurobiol. 113 (2014), 6–39.
46. Shadigan, E., Bauer, S.T., Pregnancy-associated death: a qualitative systematic review of homicide and suicide. Obstet. Gynecol. Survey 60:3 (2005), 183–190.
47. Strohle, A., Romeo, E., Hermann, B., Pasini, A., Spalletta, G., di Michele, F., Holsboer, F., Rupprecht, R., Concentrations of 3a- reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol. Psychiatry 45 (1999), 274–277.
48. Strohle, A., Pasini, A., Romeo, E., Hermann, B., Spalletta, G., di Michele, F., Holsboer, F., Rupprecht, R., Fluoxetine decreases concentrations of 3a,5a-tetrahydrodeoxycorticosterone (THDOC) in major depression. J. Psychiatr. Res. 34 (2000), 183–186.
49. Strohle, A., Romeo, E., di Michele, F., Pasini, A., Yassouridis, A., Holsboer, F., Rupprecht, R., GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am. J. Psychiatry 159 (2002), 145–147.
50. Sundstrom Poromoaa, I., Smith, S., Gulinello, M., GABA receptors, progesterone and premenstrual dysphoric disorder. Arch. Womens Men Health 6 (2003), 23–41.
51. Uzunova, V., Sheline, Y., Davis, J.M., Rasmusson, A., Uzunov, D.P., Costa, E., Guidotti, A., Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 3239–3244.
52. Uzunova, V., Sampson, L., Uzunov, D.P., Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action. Psychopharmacology (Berl.) 186:3 (2006), 351–361.
53. Yim, I.S., Tanner Stapleton, L.R., Guardino, C.M., Hahn-Holbrook, J., Dunkel Schetter, C., Biological and psychosocial predictors of postpartum depression: systematic review and call for integration. Annu. Rev. Clin. Psychol. 11 (2015), 99–137.
54. Yonkers, K.A., Vigod, S., Ross, L.E., Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstet. Gynecol. 117:4 (2011), 961–977.